tirzepatide stocks Eli Lilly stock jumps 6% after strong earnings and raised guidance 📢 Don't miss out on

Thats huge because elevated IGF-1 is the main safety worry that keeps the FDA nervous about growth hormone stuff in healthy adults

The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to what its boss described as a painful push by Donald Trump to lower US weight-loss drug prices, rising competition, and the loss of important patent protections

New study confirms GLP-1 medications are safe for mental health in diabetes

I find that inflammation often contributes to my patients systemic health conditions

Bridging Contraception Protocols : Short-term solutions such as oral contraceptives or patches can maintain coverage until Depo Provera is resumed